Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Archives of Virology
Published in: Archives of Virology 5/2014

01-05-2014 | Brief Report

HBV infection in HIV-infected subjects in the state of Piauí, Northeast Brazil

Authors: Evaldo H. Oliveira, Roseane M. C. Lima Verde, Luiz Marcelo L. Pinheiro, Marcos G. Benchimol, Ana Luisa E. D. Aragão, José Alexandre R. Lemos, Aldemir B. Oliveira-Filho, Antonio C. R. Vallinoto

Published in: Archives of Virology | Issue 5/2014

Login to get access

Abstract

In this study, the prevalence, genotype frequency, and risk factors for HBV infection in 768 HIV-infected subjects living in Piauí were determined. Forty-six (6.0 %) HIV-positive subjects were reactive for HBsAg and positive for HBV-DNA. Genotypes A (71.8 %), F (23.9 %) and D (4.3 %) were identified. Multivariate analysis revealed an association between HIV-HBV coinfection and male gender, older age groups, unprotected sex, reporting more than ten sexual partners throughout life, STD, and tattooing. This study shows the importance of monitoring sites and professionals who perform tattooing and practice safe sex to prevent the spread of HIV and HBV infections.
Literature
1.
Ganem D, Prince AM (2004) Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 350:1118–1129PubMedCrossRef
2.
Carey WD (2009) The prevalence and natural history of hepatitis B in the 21st century. Clev Clin J Med 76:S2–S5CrossRef
3.
4.
5.
Shepard CW, Simard EP, Finelli L et al (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28:112–125PubMedCrossRef
6.
De Almeida Pereira RA, Mussi AD, de Azevedo e Silva VC et al (2006) Hepatitis B virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil. BMC Infect Dis 6:34PubMedCentralPubMedCrossRef
7.
Pereira LM, Martelli CM, Merchán-Hamann E et al (2009) Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg 81:240–247PubMed
8.
Sheng WH, Kao JH, Chen PJ et al (2007) Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 45:1221–1229PubMedCrossRef
9.
Kim HN, Harrington RD, Crane HM et al (2009) Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations. Int J STD AIDS 20:595–600PubMedCrossRef
10.
Thio C (2009) Hepatitis B and human immunodeficiency virus coinfection. Hepatol 49:S138–S145CrossRef
11.
De Luca A, Bugarini R, Lepri AC et al (2002) Co-infection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med 162:2125–2132PubMedCrossRef
12.
Thio CL (2003) Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. Semin Liver Dis 23:125–136PubMedCrossRef
13.
Aires RS, Matos MA, Lopes CL et al (2012) Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil. J Clin Virol 54:327–331PubMedCrossRef
14.
Mendes-Corrêa MC, Barone AA, Cavalheiro N et al (2000) Prevalence of hepatitis B in the sera of patients with HIV infection in São Paulo, Brazil. Rev Inst Med Trop S Paulo 42:81–85PubMedCrossRef
15.
Pavan MH, Aoki FH, Monteiro DT et al (2003) Viral hepatitis in patients infected with human immunodeficiency virus. Braz J Infect Dis 7:253–261PubMedCrossRef
16.
Souza MG, Passos AD, Machado AA et al (2004) HIV and hepatitis B virus co-infection: prevalence and risk factors. Rev Soc Bras Med Trop 37:391–395PubMed
17.
Treitinger A, Spada C, Silva EL et al (1999) Prevalence of serologic markers of HBV and HCV infection in HIV-1 seropositive patients in Florianópolis, Brazil. Braz J Infect Dis 3:1–5PubMed
18.
Oliveira-Filho AB, Oliveira EH, Castro JAA et al (2012) Epidemiological aspects of HCV infection in HIV-infected individuals in Piauí State, Northeast Brazil. Arch Virol 157:2411–2416PubMedCrossRef
19.
Welzel TM, Miley WJ, Parks TL et al (2006) Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G. J Clin Microbiol 44:3325–3333PubMedCentralPubMedCrossRef
20.
Mello FC, Souto FJ, Nabuco LC et al (2007) Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates. BMC Microbiol 7:103PubMedCentralPubMedCrossRef
21.
Tamura K, Dudley J, Nei M et al (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24:1596–1599PubMedCrossRef
22.
Araújo TME, Sá LC, Santos AS et al (2012) Prevalence of hepatitis B in users of Piauí central laboratory. Rev Enferm UERJ 20:229–234
23.
Devesa M, Pujol FH (2007) Hepatitis B virus genetic diversity in Latin America. Virus Res 127:177–184PubMedCrossRef
24.
Ferreira CT, Silveira TR (2004) Viral Hepatitis: epidemiological and preventive aspects. Rev Bras Epidemiol 7:473–487CrossRef
25.
Mendes-Corrêa MC, Gomes-Gouvêa MS, Alvarado-Mora MV (2011) Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important? Int J Infect Dis 15:828–832CrossRef
26.
Matos SB, Jesus AL, Pedroza KC et al (2013) Prevalence of serological markers and risk factors for bloodborne pathogens in Salvador, Bahia state, Brazil. Epidemiol Infect 15:181–187CrossRef
27.
de Nishioka SA, Gyorkos TW, Joseph L et al (2002) Tattooing and risk for transfusion-transmitted diseases: The role of the type, number and design of the tattoos, and the conditions in which they were performed. Epidemiol Infect 128:63–71PubMedCentral
28.
Ribeiro NR, Campos GS, Angelo AL et al (2006) Distribution of hepatitis B virus genotypes among patients with chronic infection. Liver Int 26:636–642PubMedCrossRef
29.
Viana S, Paraná R, Moreira RC et al (2005) High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg 73:808–814PubMed
Metadata
Title
HBV infection in HIV-infected subjects in the state of Piauí, Northeast Brazil
Authors
Evaldo H. Oliveira
Roseane M. C. Lima Verde
Luiz Marcelo L. Pinheiro
Marcos G. Benchimol
Ana Luisa E. D. Aragão
José Alexandre R. Lemos
Aldemir B. Oliveira-Filho
Antonio C. R. Vallinoto
Publication date
01-05-2014
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 5/2014
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1921-2

Other articles of this Issue 5/2014

Archives of Virology 5/2014 Go to the issue

Annotated Sequence Record

A distinct strain of chickpea chlorotic dwarf virus (genus Mastrevirus, family Geminiviridae) identified in cotton plants affected by leaf curl disease

Brief Review

The role of microRNAs in hepatitis C virus RNA replication

Original Article

Effect of age on the pathogenesis of DHV-1 in Pekin ducks and on the innate immune responses of ducks to infection

Brief Review

Current and future therapies for hepatitis C virus infection: from viral proteins to host targets

Original Article

Genetic heterogeneity in the leader and P1-coding regions of foot-and-mouth disease virus serotypes A and O in Africa

Original Article

Understanding internalization of rotavirus VP6 nanotubes by cells: towards a recombinant vaccine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits